Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells (original) (raw)
References
Suda, T., Takahashi, T., Golstein, P. & Nagata, S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell75, 1169–1178 (1993). ArticleCAS Google Scholar
Suda, T. et al. Expression of the Fas ligand in cells of the T lineage. J. Immunol.154, 3806–3813 (1995). CAS Google Scholar
Hahne, M. et al. Activated B cells express functional Fas ligand. Eur. J. Immunol.26, 721–724 (1996). ArticleCAS Google Scholar
Saas, P. et al. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain. J. Clin. Invest.99, 1173–1178 (1997). ArticleCAS Google Scholar
Arase, H., Arase, N. & Saito, T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med.181, 1235– 1238 (1995). ArticleCAS Google Scholar
Ju, S.T. et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature373, 345–348 (1995). Article Google Scholar
Brunner, T. et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature373, 342–345 (1995). Article Google Scholar
Renno, T., Hahne, M., Tschopp, J. & MacDonald, H.R. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J. Exp. Med.183, 431–437 (1996). ArticleCAS Google Scholar
Kimura, M. & Matsuzawa, A. Autoimmunity in mice bearing lpr.cg: a novel mutant gene. Int. Rev. Immunol.11, 193–210 (1994). ArticleCAS Google Scholar
Hahne, M. et al. Characterization of the non-functional Fas ligand of gld mice. Int. Immunol.7, 1381– 1386 (1995). ArticleCAS Google Scholar
Chervonsky, A.V. et al. The role of Fas in autoimmune diabetes. Cell89, 17–24 (1997). ArticleCAS Google Scholar
Kondo, T., Suda, T., Fukuyama, H., Adachi, M. & Nagata, S. Essential role of the Fas ligand in the development of hepatitis. Nature Med.3, 409– 413 (1997). ArticleCAS Google Scholar
Giordano, C. et al. Potential Involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science275, 960–963 (1997). ArticleCAS Google Scholar
Itoh, N. et al. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med.186, 613–618 (1997). ArticleCAS Google Scholar
Hahne, M. et al. Melanoma cell expression of Fas(Apo-a/CD95) Ligand: Implications for tumor immune escape. Science274, 1363–1366 (1996). ArticleCAS Google Scholar
O'Connell, J., O'Sullivan, G.C., Collins, J.K. & Shanahan, F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med.184, 1075– 1082 (1996). ArticleCAS Google Scholar
Niehans, G.A. et al. Human lung carcinomas express Fas ligand. Cancer Res.57, 1007–1012 (1997). CASPubMed Google Scholar
Tanaka, M. et al. Fas ligand in human serum. Nature Med.2, 317–322 (1996). ArticleCAS Google Scholar
Seino, K., Kayagaki, N., Okumura, K. & Yagita, H. Anti-tumor effect of locally produced CD95L. Nature Med.3, 165–170 (1997). ArticleCAS Google Scholar
Arai, H., Chan, S.Y., Bishop, D.K. & Nabel, G.J. Inhibition of the alloantibody response by CD95 ligand. Nature Med.3, 843–848 (1997). ArticleCAS Google Scholar
Corry, D.B., Reiner, S.L., Linsley, P.S. & Locksley, R.M. Differential Effects of Blockade of CD28-B7 on the Development of Th1 or Th2 Effector Cells in Experimental Leishmaniasis. J. Immunol.153, 4142–4148 (1994). CAS Google Scholar
Kaneko, S., Suzuki, N., Koizumi, H., Yamamoto, S. & Sakane, T. Rescue by cytokines of apoptotic cell death induced by IL-2 deprivation of human antigen-specific T cell clones. Clin. Exp. Immunol.109, 185–193 (1997). ArticleCAS Google Scholar
Dou, Q.P., An, B., Antoku, K. & Johnson, D.E. Fas stimulation induces RB dephosphorylation and proteolysis that is blocked by inhibitors of the ICE protease family. J. Cell. Biochem.64, 586–594 (1997). ArticleCAS Google Scholar
Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. & Nagata, S. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature356, 314–317 (1992). ArticleCAS Google Scholar
Chu, J.L. et al. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med.181, 393– 398 (1995). ArticleCAS Google Scholar
Herman, A., Kappler, J., Marrack, P. & Pullen, A.M. Superantigens: Mechanisms of T-Cell Stimulation and Role in Immune Responses. Ann. Rev. Immunol.9, 745–772 (1991). ArticleCAS Google Scholar
Jardetzky, T.S. et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature368, 711–718 (1994). ArticleCAS Google Scholar
Krummel, M.F. & Allison, J.P. CTLA-4 Engagement Inhibits IL-2 Accumulation and Cell-cycle Progression upon Activation of Resting T cells. J. Exp. Med.183, 2533– 2540 (1996). ArticleCAS Google Scholar
Krummel, M.F. & Allison, J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med.182, 459–463 (1995). ArticleCAS Google Scholar
Walunas, T.L., Bakker, C.Y. & Bluestone, J.A. CTLA-4 Ligation Blocks CD28-dependent T Cell Activation. J. Exp. Med.183, 2541– 2550 (1996). ArticleCAS Google Scholar
Suzuki, I. & Fink, P.J. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas Ligand. J. Exp. Med.187, 123–128 (1998). ArticleCAS Google Scholar
Hutchings, P. et al. The regulation of autoimmunity through CD4+ T cells. Autoimmunity15, 21–23 (1993). Article Google Scholar
Chandler, C. & Passaro, E., Jr. Transplant Rejection. Mechanisms and treatment. Arch. Surgery128, 279– 283 (1993). ArticleCAS Google Scholar
Prud'homme, G.J. & Vanier, L.E. Cyclosporine, tolerance, and autoimmunity. Clin. Immunol. Immunopathol.66, 185–192 (1993). ArticleCAS Google Scholar
Bellgrau, D. et al. A role for CD95 ligand in preventing graft rejection. Nature377, 630–632 (1995). ArticleCAS Google Scholar
Allison, J., Georgiou, H.M., Strasser, A. & Vaux, D.L. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc. Natl. Acad. Sci. USA94, 3943– 3947 (1997). ArticleCAS Google Scholar
Seino, K., Kayagaki, N., Fukao, K., Okumura, K. & Yagita, H. Rejection of Fas ligand-expressing grafts. Transplant. Proc.29, 1092–1093 (1997). ArticleCAS Google Scholar
Kang, S.-M. et al. Fas ligand expression in islet of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Med.3, 738–743 (1997). ArticleCAS Google Scholar
Lau, H.T. & Stoeckert, C.J. FasL—Too much of a good thing? Nature Med.3, 727– 728 (1997). ArticleCAS Google Scholar
Gillis, S. & Smith, K.A. Long term culture of tumor-specific cytotoxic T cells. Nature268, 154– 156 (1997). Article Google Scholar